Rev1 Founders' Story: Isaiah Shalwitz of Invirsa, Inc.

Founders’ Story brings the startup community together for candid conversations with founders building and scaling companies.

On May 13, we’re featuring Isaiah Shalwitz, Co-Founder of Invirsa, for a session especially relevant to those working in life sciences.

Join us for coffee and networking and connect with scientists, clinicians, founders, and operators from across the life sciences ecosystem. You’ll then hear directly from Isaiah as he shares the path behind building Invirsa – from early scientific insight to development, validation, and commercialization.

Invirsa is developing INV-102, a compound designed to enhance the body’s response to DNA damage and improve cell stability, with potential applications in ocular and respiratory therapies. Isaiah brings deep experience in pharmaceutical development and will speak candidly about the realities of advancing science into a viable company.

Why attend:

•       Understand how research translates into a company

•       Hear practical insights on development, regulatory considerations, and funding

•       Connect with others working across the life sciences ecosystem

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Rev1 Ventures